Finance

Lists
Outlook: 93.5% bullish·0.0% bearish
Go to analysis
THC:NYSE
Tenet Healthcare Corp
US$ २८३.३३
-१.०९%
(-३.१३) 1D
US$ २८४.००
+०.२४% (+०.६७)
After hours
Closed: नोभेम्बर ६, १६:००:०३ GMT-५  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for THC...
Open
US$ २८०.००
High
US$ २८५.७६
Low
US$ २७६.८७
Mkt. cap
२२.५५ अरब
Avg. vol.
७.६८ लाख
Volume
६.३२ लाख
P/E ratio
८.२२
52-wk high
US$ २९४.१०
52-wk low
US$ १५७.५८
EPS
US$ ३४.४८
Beta
१.२०
Shares outstanding
७.९६ करोड
No. of employees
८८ हजार
Open
US$ २८०.००
High
US$ २८५.७६
Low
US$ २७६.८७
Mkt. cap
२२.५५ अरब
Avg. vol.
७.६८ लाख
Volume
६.३२ लाख
P/E ratio
८.२२
52-wk high
US$ २९४.१०
52-wk low
US$ १५७.५८
EPS
US$ ३४.४८
Beta
१.२०
Shares outstanding
७.९६ करोड
No. of employees
८८ हजार
News stories
From web sources and news partners
Profile
Tenet Healthcare Corporation is an American for-profit multinational healthcare services company based in Dallas. Through its brands, subsidiaries, joint ventures, and partnerships including United Surgical Partners International, the company operates around 65 hospitals and over 450 healthcare facilities. Tenet also runs Conifer Health Solutions, which provides healthcare support services to health systems and other clients. Since its founding in 1969, Tenet has expanded significantly. Among other major acquisitions and formations, Tenet founded Conifer Health Solutions in 2008, MedPost Urgent Care in 2014, and in 2013 acquired Vanguard Health Systems, Inc., an investor-owned hospital company whose operations complemented Tenet's existing business. The acquisition created the third-largest investor-owned hospital company in the United States in terms of revenue and the third-largest in number of hospitals owned. In 2015, Tenet acquired USPI, which created the largest operator of outpatient surgery centers in the U.S. In 2021, the company ranked 167th in the Fortune 500. Wikipedia
About Tenet Healthcare Corp
CEOSaum Sutaria
Employees८८.५ हजार
Founded१९६९
Headquartersडलास, टेक्सस, संयुक्त राज्य अमेरिका
SectorHealth Care
Industry-
Analyst ratings
Based on 15 analysts giving stock ratings to THC in the past 3 months
Strong buy
Buy
13
Hold
2
Sell
0
12-month forecast
Based on 15 Wall Street analysts offering 12 month price targets for THC in the last 3 months.
Highest
Current US$ २८३.३३
US$ ३४२.०० (+२०.७१%)
Average
US$ ३०५.६४ (+७.८७%)
Lowest
US$ २६५.०० (-६.४७%)
Analyst
Recommendation
Action
Price target
Projected
Date
Kevin Fischbeck
Bank of America Securities
Buy
Maintained
-
-
11/05/2026
Andrew Mok CFA
Barclays
Buy
Maintained
US$ २९७.००
+४.८%
11/04/2026
Matthew Gillmor CFA
KeyBanc
Buy
Maintained
US$ ३००.००
+५.९%
11/03/2026
Whit Mayo
Leerink Partners
Buy
Reiterated
US$ ३४२.००
+२०.७%
11/02/2026
A.J. Rice
UBS
Buy
Maintained
US$ ३४०.००
+२०%
11/02/2026
Ben Hendrix
RBC Capital
Buy
Reiterated
US$ ३०४.००
+७.३%
11/01/2026
Ryan Langston
TD Cowen
Buy
Maintained
US$ ३०२.००
+६.६%
11/02/2026
Ann Hynes
Mizuho Securities
Buy
Maintained
US$ ३०५.००
+७.६%
11/02/2026
Stephen Baxter
Wells Fargo
Buy
Maintained
US$ ३२१.००
+१३.३%
11/02/2026
John Ransom
Raymond James
Buy
Maintained
US$ ३००.००
+५.९%
10/30/2026
Craig Hettenbach
Morgan Stanley
Buy
Reiterated
US$ २९७.००
+४.८%
10/30/2026
Sean Dodge
BMO Capital
Hold
Reiterated
US$ २६५.००
-६.५%
10/29/2026
Jason Cassorla
Guggenheim
Buy
Maintained
US$ ३०६.००
+८%
10/29/2026
Michael Ha
Robert W. Baird
Hold
Maintained
US$ २८५.००
+०.६%
10/30/2026
Andrew Cooper
Raymond James
Buy
Reiterated
US$ २८५.००
+०.६%
09/28/2026
Benjamin Rossi
J.P. Morgan
Buy
Maintained
US$ ३१५.००
+११.२%
09/01/2026
Scott Fidel
Goldman Sachs
Buy
Reiterated
US$ ३०५.००
+७.६%
07/29/2026
Unknown Analyst
Stephens
Buy
Maintained
US$ २८५.००
+०.६%
07/27/2026
Raj Kumar CFA
Stephens
Buy
Maintained
US$ २८५.००
+०.६%
07/27/2026
David S Macdonald
Truist Financial
Buy
Reiterated
US$ २९०.००
+२.४%
07/28/2026
Sarah James
Cantor Fitzgerald
Buy
Maintained
US$ २४५.००
-१३.५%
07/23/2026
Last report
२०२६ अक्टोबर २९
Fiscal period
Q3 2026
US$ ६.६४ / US$ ४.६८
+४२.०१%beat
Revenue / Est. (USD)
५.६३ अरब / ५.५१ अरब
+२.१९%beat
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
२०२६ सेप्टेम्बर
Revenue
५.५३ अरब
५.३७ अरब
५.६३ अरब
५.६३ अरब
Cost of goods sold
३.२३ अरब
३.१४ अरब
३.२२ अरब
३.१६ अरब
Cost of revenue
३.२३ अरब
३.१४ अरब
३.२२ अरब
३.१६ अरब
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
४१.०० करोड
१०.२० करोड
१०.४० करोड
१०.५० करोड
Operating expense
१.३३ अरब
१.२७ अरब
१.३९ अरब
१.४० अरब
Total operating expenses
४.५६ अरब
४.४० अरब
४.६१ अरब
४.५६ अरब
Operating income
९६.५० करोड
९६.३० करोड
१.०२ अरब
१.०७ अरब
Other non operating income
३.९० करोड
४.३० करोड
४.५० करोड
३.९० करोड
EBT including unusual items
६८.१० करोड
१.१३ अरब
१.३४ अरब
१.५८ अरब
EBT excluding unusual items
८८.२० करोड
८५.२० करोड
९२.८० करोड
९७.२० करोड
Income tax expense
३.७० करोड
२२.६० करोड
२९.५० करोड
३६.०० करोड
Effective tax rate
५.४३%
१९.९६%
२२.०१%
२२.८०%
Other operating expenses
६८.७० करोड
९३.७० करोड
१.०७ अरब
१.०८ अरब
Net income
३७.१० करोड
७०.२० करोड
८२.६० करोड
१.०० अरब
Net profit margin
६.७१%
१३.०८%
१४.६८%
१७.७६%
Earnings per share
४.७०
४.८२
६.१२
६.६४
Interest and investment income
-
-
-
-
Interest expense
-२०.५० करोड
-२०.५० करोड
-२०.४० करोड
-२०.३० करोड
Net interest expenses
-२०.५० करोड
-२०.५० करोड
-२०.४० करोड
-२०.३० करोड
Depreciation and amortization charges
२३.१० करोड
२२.९० करोड
२१.५० करोड
२१.७० करोड
EBITDA
१.२० अरब
१.१९ अरब
१.२४ अरब
१.२९ अरब
Gain or loss from assets sale
५०.०० लाख
-१०.०० लाख
-३.३० करोड
-९०.०० लाख
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google एपहरू